OpenAI's acquisition of Orchestra Bio

On October 20, 2026 OpenAI acquired Orchestra Bio, a startup building AI agents that help pharmaceutical companies manage drug development, and said it would fold the startup into its Rosalind life sciences models and tools; financial terms were not disclosed.